Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308932 · ClinicalTrials.gov registry record · Phase 4
Effect of Age and Device on Delivery of Fluticasone
A Phase 4 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00308932 is a Phase 4 study that has completed, run by University of Florida. The registered enrollment target is 60 participants.
The verdict
NCT00308932, a Phase 4 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
To determine the effect of age and device on delivery of HFA-Fluticasone Propionate (FP) in children of different ages. Hypothesis -- passive inhalation in younger children through a valved holding chamber/mask (VHC) will reduce the relative amount of FP delivered to airways.
Interventions
- DRUG HFA FP MDI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2003-02 |
| Est. Completion | 2004-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00308932
The ClinicalTrials.gov registry entry for NCT00308932 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HFA FP MDI is the first listed.
NCT00308932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00308932 about?
NCT00308932 is a clinical study titled "Effect of Age and Device on Delivery of Fluticasone". To determine the effect of age and device on delivery of HFA-Fluticasone Propionate (FP) in children of different ages. Hypothesis -- passive inhalation in younger children through a valved holding chamber/mask (VHC) will reduce the relative amount of FP delivered to airways.
What is the current status of trial NCT00308932?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2003-02. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00308932?
The interventions under investigation include: HFA FP MDI (DRUG).
Who is sponsoring clinical trial NCT00308932?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.